» Articles » PMID: 20396601

Mitochondrial Translation and Beyond: Processes Implicated in Combined Oxidative Phosphorylation Deficiencies

Overview
Specialty Biology
Date 2010 Apr 17
PMID 20396601
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial disorders are a heterogeneous group of often multisystemic and early fatal diseases, which are amongst the most common inherited human diseases. These disorders are caused by defects in the oxidative phosphorylation (OXPHOS) system, which comprises five multisubunit enzyme complexes encoded by both the nuclear and the mitochondrial genomes. Due to the multitude of proteins and intricacy of the processes required for a properly functioning OXPHOS system, identifying the genetic defect that underlies an OXPHOS deficiency is not an easy task, especially in the case of combined OXPHOS defects. In the present communication we give an extensive overview of the proteins and processes (in)directly involved in mitochondrial translation and the biogenesis of the OXPHOS system and their roles in combined OXPHOS deficiencies. This knowledge is important for further research into the genetic causes, with the ultimate goal to effectively prevent and cure these complex and often devastating disorders.

Citing Articles

Improving human cardiac organoid design using transcriptomics.

Hyams N, Kerr C, Arhontoulis D, Ruddy J, Mei Y Sci Rep. 2024; 14(1):20147.

PMID: 39209865 PMC: 11362591. DOI: 10.1038/s41598-024-61554-w.


Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules.

Roy T, Padhi S, Mazumder R, Majee C, Das S, Monika Curr Top Med Chem. 2024; 24(16):1377-1407.

PMID: 38591201 DOI: 10.2174/0115680266299148240329062647.


β2-glycoprotein I promotes the clearance of circulating mitochondria.

Dasgupta S, Gollamudi J, Rivera S, Poche R, Rumbaut R, Thiagarajan P PLoS One. 2024; 19(1):e0293304.

PMID: 38271349 PMC: 10810532. DOI: 10.1371/journal.pone.0293304.


Expanding the spectrum of neonatal-onset AIFM1-associated disorders.

Zambon A, Ghezzi D, Baldoli C, Cutillo G, Fontana K, Sofia V Ann Clin Transl Neurol. 2023; 10(10):1844-1853.

PMID: 37644805 PMC: 10578896. DOI: 10.1002/acn3.51876.


The mRNA translation initiation factor eIF4G1 controls mitochondrial oxidative phosphorylation, axonal morphogenesis, and memory.

Kim S, Choi J, Marsal-Garcia L, Amiri M, Yanagiya A, Sonenberg N Proc Natl Acad Sci U S A. 2023; 120(25):e2300008120.

PMID: 37307456 PMC: 10288579. DOI: 10.1073/pnas.2300008120.


References
1.
Artal-Sanz M, Tavernarakis N . Prohibitin and mitochondrial biology. Trends Endocrinol Metab. 2009; 20(8):394-401. DOI: 10.1016/j.tem.2009.04.004. View

2.
Guan M, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P . Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet. 2006; 79(2):291-302. PMC: 1559489. DOI: 10.1086/506389. View

3.
Schon E, Dencher N . Heavy breathing: energy conversion by mitochondrial respiratory supercomplexes. Cell Metab. 2009; 9(1):1-3. DOI: 10.1016/j.cmet.2008.12.011. View

4.
Saada A . Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell Biol. 2005; 23(12):797-806. DOI: 10.1089/dna.2004.23.797. View

5.
Blesa J, Solano A, Briones P, Prieto-Ruiz J, Hernandez-Yago J, Coria F . Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene. Neuromolecular Med. 2007; 9(4):285-91. DOI: 10.1007/s12017-007-8000-3. View